Ivermectin Orifarm Healthcare

Ivermectin, the active ingredient in Ivermectin Orifarm Healthcare, is an anthelmintic presented as a tablet for oral use. It treats parasitic worm infections and certain ectoparasitic conditions in humans.\n\nGNH India supplies Ivermectin Orifarm Healthcare as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivermectin is an antiparasitic agent used to treat a range of helminth and ectoparasite infections.\n\n- Strongyloidiasis: eliminates intestinal Strongyloides stercoralis larvae and adult worms.\n- Onchocerciasis: reduces microfilarial load of Onchocerca volvulus, helping control river blindness.\n- Scabies: eradicates Sarcoptes scabiei mites, relieving skin infestation.\n- Lymphatic filariasis: decreases microfilariae of Wuchereria bancrofti, contributing to disease control.\n- Other helminth infections: targets various nematodes such as hookworms and pinworms.

Adverse reactions may vary in frequency and severity.\n\nCommon Side Effects:\n- Dizziness: transient sensation of light‑headedness.\n- Nausea: mild to moderate stomach upset.\n- Diarrhea: loose stools occurring shortly after dosing.\n- Headache: mild to moderate pain in the head region.\n\nSerious or Rare Side Effects:\n- Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.\n- Hepatic dysfunction: elevated liver enzymes or jaundice.\n- Anaphylaxis: acute, potentially life‑threatening allergic response.

Before prescribing Ivermectin, consider the following safety measures.\n\n- Assess for Loa loa infection: avoid use in patients with high microfilaremia due to risk of severe reactions.\n- Monitor liver function: check baseline hepatic enzymes in patients with liver disease.\n- Avoid in known hypersensitivity: discontinue if allergic signs appear.\n- Use caution in pregnancy: weigh benefits against potential risks.\n- Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Ivermectin may interact with other medicines; review patient medication lists.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase ivermectin plasma levels.\n- P‑glycoprotein inhibitors (e.g., verapamil): can raise systemic exposure.\n\nModerate Interactions (Monitor Closely):\n- Warfarin: potential for enhanced anticoagulant effect, monitor INR.\n- Statins (e.g., simvastatin): increased risk of myopathy, observe muscle symptoms.\n- Antiepileptic drugs (e.g., carbamazepine): may reduce ivermectin efficacy.